lung infection articles & resources on Made-in-China.com

A New Study Clarifies Some of The Factors That Put Certain Kids at Greater Risk

Jan 15, 2014

Frequent colds are a normal part of young children's lives, but sometimes a stuffy nose becomes a more severe lung infection. Now, a new study clarifies some of the factors that put certain kids at greater risk. The study, published ...

Tags: kids health, frequent colds, human rhinoviruses, common cold, risks

CFFT Has Provided $1.7m Research Award to US-based Savara Pharmaceuticals

Oct 21, 2013

Cystic Fibrosis Foundation Therapeutics (CFFT), an affiliate of the CF Foundation, has provided $1.7m research award to US-based Savara Pharmaceuticals for advancing the development of AeroVanc (vancomycin hydrochloride inhalation powder). ...

Tags: Savara Pharmaceuticals, Aerovanc Development

Sigma-Tau PharmaSource Has Entered Into a Manufacturing Services Agreement with Aradigm

Sep 18, 2013

Biopharmaceutical contract manufacturer Sigma-Tau PharmaSource has entered into a manufacturing services agreement with Aradigm, a specialty pharmaceutical firm focused on the development and commercialization of drugs delivered by ...

Tags: Sigma-Tau, Aradigm

Novartis TOBI Podhaler 28mg Per Capsule Has Obtained FDA Approval

Mar 26, 2013

c (tobramycin inhalation powder) 28mg per capsule has obtained FDA approval for the treatment of bacterial lung infection in certain cystic fibrosis (CF) patients. TOBI Podhaler is new non-nebulized formulation and delivery system of ...

Tags: FDA, cystic fibrosis patients, lung infection

lung infection

A New Study Clarifies Some of The Factors That Put Certain Kids at Greater Risk

CFFT Has Provided $1.7m Research Award to US-based Savara Pharmaceuticals

Sigma-Tau PharmaSource Has Entered Into a Manufacturing Services Agreement with Aradigm

Novartis TOBI Podhaler 28mg Per Capsule Has Obtained FDA Approval

Related Products